Towards a novel treatment strategy for acute pancreatitis: 1. Reappraisal of the evidence on aetiogenesis

Digestion

Volumn 63, Issue 2, 2001, Pages 69-91

  Braganza, Joan M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute pancreatitis aetiogenesis; Anaphylactoid reaction; Autodigestion; Colocalization; Contact system; Mast cell; Multiple organ dysfunction syndrome; Oxidative stress; Signal transduction; Systemic inflammatory response syndrome; Xenobiotics

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CERULETIDE; CYTOCHROME P450; CYTOKINE; ETHIONINE; FREE RADICAL; GLUTATHIONE; HEPARIN; INTERLEUKIN 1; LINOLEIC ACID; METHIONINE; SELENIUM; SNARE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN; TRYPSINOGEN; TUMOR NECROSIS FACTOR ALPHA;

ACINAR CELL; ACUTE PANCREATITIS; CHOLESTASIS; DIGESTION; DISEASE COURSE; ENZYME ACTIVATION; ENZYME RELEASE; EXPERIMENTAL MODEL; HUMAN; MAST CELL; MULTIPLE ORGAN FAILURE; NEUTROPHIL; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; XENOBIOTIC METABOLISM;

ACUTE DISEASE; ANIMALS; FREE RADICALS; HUMANS; MAST CELLS; OXIDATIVE STRESS; PANCREATITIS;

EID: 0035106515     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051875     Document Type: Review

References (235)

1. Acute pancreatitis: A consideration of pancreatic haemorrhage, haemorrhagic, suppurative, and gangrenous pancreatitis, and of disseminated fat-necrosis
2. Acute pancreatitis: A lethal disease of increasing incidence
3. Prevalence and prediction of multiple organ system failure and mortality in acute pancreatitis
4. Death due to acute pancreatitis: A retrospective analysis of 405 autopsy cases
5. High early mortality rate from acute pancreatitis in Scotland, 1984-1995
6. Indications for surgery in necrotizing pancreatitis: A millenial review
7. Current concepts of the pathophysiology and treatment of severe acute pancreatitis
8. A clinical and morphologic study of forty-two cases of fatal acute pancreatitis
9. Acute pancreatitis
10. Fatal pancreatitis, a consequence of excessive leukocyte stimulation?
11. Free radicals and pancreatitis
12. Assessment and Treatment of Pancreatic Disease: New Horizons and Aspects
13. Acute pancreatitis
14. Pancreas Update
15. The role of cytokines in the pathogenesis of acute pancreatitis
16. The inflammatory response in acute pancreatitis
17. Hereditary pancreatitis: New insights into acute and chronic pancreatitis
18. Inflammatory mediators in acute pancreatitis
19. Acute pancreatitis
20. The natural history of the systemic inflammatory response syndrome (SIRS)
21. Über die Selbstverdauung des menschlichen Pankreas
22. Treating patients with severe sepsis
23. Tissue destruction by neutrophils
24. Inactivation of plasminogen activator inhibitor by oxidants
25. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor
26. Pancreatic secretory enzymes
27. Interaction between nutrients, pro-inflammatory cytokines and inflammation
28. Lipid peroxidation and antioxidants as biomarkers of tissue damage
29. Genetic determinants of mortality in acute necrotizing pancreatitis
30. The effects of intravenous antioxidants in patients with septic shock
31. Selenium replacement in severe systemic inflammatory response syndrome
32. Nuclear factor kappa B: A pivotal role in the systemic inflammatory response syndrome and new target for therapy
33. Role of enzyme inhibitors in acute pancreatitis and rationale for therapeutic use
34. Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha-2-macroglobulin-protease complexes in severe and mild attacks
35. Investigation of the interleukin 1 gene cluster and its association with acute pancreatitis
36. Risk factors in acute pancreatitis
37. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis
38. The scientific basis of medical therapy of acute pancreatitis
39. Free radical-induced oxidation of glycerophosphocholine lipids and formation of biologically active products
40. Clinical trial of 24 hours' treatment with glutathione precursors in acute pancreatitis
41. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopan-creatography
42. Gabexate mesilate in human acute pancreatitis
43. Serine protease inhibition prevents both cellular and humoral responses to cardio-pulmonary bypass
44. Protease inhibitors (gabexate mesylate and ulinstatin) stimulate intracellular chemiluminescence in human neutrophils
45. 2) and hydroxyl radical production by human polymorphonuclear leukocytes
46. Oxidative stress in acute pancreatitis
47. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats
48. Heparin and inflammation: A new use for an old GAG?
49. The inhibitory effect of heparin on trypsinogen activation with enterokinase
50. Prevention of post-ERCP pancreatitis (AP) by heparin: A prospective study with respect to risk factors (RF) for AP
51. Kallikrein-kinin system in acute pancreatitis: Potential of B(2)-bradykinin antagonists and kallikrein inhibitors
52. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin
53. A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis
54. Experimental acute pancreatitis
55. Experimental animal models of acute pancreatitis
56. Experimental models of acute pancreatitis
57. Foreign serum-induced pancreatitis in mice
58. New model of acute necrotizing pancreatitis induced by excessive doses of arginine in rats
59. Pathology of pancreatitis
60. Oxygen radical generation and acute pancreatitis: Effects of dibutyltin/ethanol and ethanol on rat pancreas
61. On the mechanism of experimentally induced ethionine pancreatitis
62. Toxicology of the pancreas
63. A framework for the aetiogenesis of chronic pancreatitis
64. The role of the liver in exocrine pancreatic disease
65. Exocrine pancreatic secretion in acute experimental pancreatitis
66. The concept of flow and compartmentation in understanding the pathobiology of pancreatitis
67. In vitro experiments to study the role of contrast medium in pancreatitis due to ERCP
68. Pancreatic secretory responses in L-arginine-induced pancreatitis: Comparison of diabetic and nondiabetic rats
69. Intracellular transport of pancreatic enzymes
70. Analysis in the isolated perfused cat pancreas of factors implicated in the pathogenesis of pancreatitis
71. Acute pancreatitis in rats: Effects of sodium taurocholate, CCK-8 and Sec on pancreatic microcirculation
72. Phasic release of newly synthesized secretory proteins in the unstimulated rat exocrine pancreas
73. Routes of protein secretion in the isolated perfused cat pancreas
74. Microcirculatory dynamics in the normal and inflamed pancreas
75. Mechanism of blood enzyme changes following the production of experimental pancreatitis
76. Exit routes for secretory proteins from the dog pancreas
77. Increased peritoneal permeability in acute experimental pancreatitis
78. Pathways for enzyme transfer in sodium taurocholate-induced acute hemorrhagic pancreatitis
79. A hypothesis: SNARE-ing the mechanisms of regulated exocytosis and pathologic membrane fusions in the pancreatic acinar cell
80. Remarkable stimulation of pancreatic fluid secretion by CCK-58 is independent of secretin
81. q/11 localized on pancreatic zymogen granules is involved in calcium-regulated amylase secretion
82. Changes in zymogen granule membrane and pancreatic juice after supramaximal stimulation with caerulein in the rat
83. Pancreatic exocrine secretion is blocked by inhibitors of methylation
84. S-adenosyl-L-methionine protects against haemorrhagic pancreatitis in partially immunosuppressed pancreatico-duodenal transplant recipients
85. Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro
86. Xenobiotic metabolism, oxidant stress and chronic pancreatitis: Focus on glutathione
87. Cobalamin and folate: Recent developments
88. Folate deficiency inhibits pancreatic amylase secretion in rats
89. Unequivocal evidence in support of nonenyzmic redox coupling between glutathione/glutathione disulfide and ascorbic acid/ dehydroascorbic acid
90. Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs
91. Glutathione depletion inhibits amylase release in guinea pig pancreatic acini
92. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthase inactivation and attenuates liver injury
93. 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy
94. Serial alterations in the forms of immunoreactive trypsin in plasma from patients with acute pancreatitis
95. Evolution of pancreatitis
96. A novel exocrine protein associated with pancreas transplantation in humans
97. Morphological studies of graft pancreatitis following pancreas transplantation
98. Fine structural and biochemical studies in human acute pancreatitis
99. Sulfur amino acid metabolism in chronic relapsing pancreatitis
100. Evidence for early oxidative stress in acute pancreatitis: Clues for correction
101. Blood glutathione and adenylates in acute pancreatitis
102. Studies towards interpretation of trypsinogen activation in acute pancreatitis. Proceedings of the Pancreatic Society of Great Britain and Ireland, London November 1999
103. 2) plasma polymorphonuclear elastase (PMN-E) in different-severity forms of human AP
104. Vitamin C status in patients with acute pancreatitis
105. Oxidative stress: An important phenomenon with pathogenic significance in the progression of acute pancreatitis
106. Early ascorbic acid depletion is related to the severity of acute pancreatitis
107. Prospective randomized placebo-controlled trial of ascorbic acid in human acute pancreatitis
108. Blood glutathione and folate in acute pancreatitis
109. The role of oxygen radicals in acute pancreatitis. Clinical and experimental results of therapy with free radical scavengers
110. Relationship of carotenoid and vitamins A and E with the acute inflammatory response in acute pancreatitis
111. Lipo-soluble antioxidants are not consumed in the pancreas after reperfusion in human simultaneous pancreas-kidney transplantation
112. The antioxidant profiles of patients with recurrent acute and chronic pancreatitis
113. Placebo-controlled trials of antioxidant therapy including S-adenosylmethionine in patients with recurrent non-gallstone pancreatitis
114. Pancreatitis is Soweto, South Africa: Focus on alcohol-related disease
115. Micronutrient antioxidant status in tropical compared with temperate-zone chronic pancreatitis
116. Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis
117. Biochemical vitamin E deficiency in chronic pancreatitis
118. Antioxidants, enzyme induction, and chronic pancreatitis: A reappraisal following studies in patients on anticonvulsants
119. Renal and hepatic output of glutathione in plasma and whole blood
120. Erythrocyte ascorbate recycling: Antioxidant effects in blood
121. A pilot study of antioxidant intake in patients with cholesterol gallstones
122. Contribution à l'étude des cellules glandulaires (pancreas)
123. Is an elevated concentration of acinar cytosolic free ionised calcium the trigger for acute pancreatitis?
124. Membrane wounding of acinar cells is an early event in experimental acute pancreatitis
125. The role of oxygen derived free radicals in the pathogenesis of acute pancreatitis
126. Pancreatic disease: A casualty of hepatic 'detoxification'?
127. Transition of pancreatic edema into pancreatic necrosis
128. Experimental pancreatitis
129. Acute hemorrhagic pancreatic necrosis produced by local Shwartzman reaction
130. Mast cell: Pivotal player in lethal acute pancreatitis
131. The role of resistance arteries in the pathogenesis of hypertension
132. Experimental and pathological studies of the pathogenesis of acute haemorrhagic pancreatitis
133. Stress-activated protein kinase activation is the earliest direct correlate to the induction of secretagogue-induced pancreatitis in rats
134. Inhibition of trypsin and chymotrypsin by thiols: Biphasic kinetics of reactivation and inhibition induced by sodium periodate addition
135. Trypsinogen activation and glutathione content are linked to pancreatic injury in models of biliary acute pancreatitis
136. Generation and possible significance of trypsinogen activation peptides in experimental acute pancreatitis in the rat
137. Activation of trypsinogen in experimental models of acute pancreatitis in rats
138. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis
139. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis
140. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis
141. Platelet activating factor mediates pancreatic function derangement in caerulein-induced pancreatitis in rats
142. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage
143. Induction of acute pancreatitis in germ-free rats: Evidence of a primary role for tumor necrosis factor-alpha
144. Systemic endotoxin, antiendotoxin antibodies and proinflammatory cytokines in the taurocholate model of acute pancreatitis
145. Platelet-activating factor: A mediator of pancreatic inflammation during cerulein hyperstimulation
146. Demonstration of tumour necrosis factor in pancreatic acinar cells by in situ hybridisation in a model of acute pancreatitis
147. Pancreatic acinar cells produce, release and respond to tumour necrosis factor-α: Role in regulating cell death and pancreatitis
148. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis
149. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis
150. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats
151. Early acinar cell changes in caerulein-induced interstitial acute pancreatitis in the rat
152. Role of oxidative stress in the pathogenesis of acute pancreatitis
153. The mechanism of conversion of xanthine dehydrogenase to xanthine oxidase in acute pancreatitis in the canine isolated pancreas preparation
154. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
155. The pancreas
156. 2-Isoprostane and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders
157. Occupational chemicals and pancreatitis: A link?
158. Occupational exposure to hydrocarbons and chronic pancreatitis: A case referent study
159. Toxicology of the pancreas
160. Induction of drug-metabolising enzymes in human pancreatic cancer and chronic pancreatitis
161. Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis
162. Synthesis of steroids in pancreas: Evidence of cytochrome P-450scc activity
163. Acute pancreatitis: A free radical disease: Reducing the lethality with sodium selenite and other antioxidants
164. Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation
165. Lipid peroxidation and antioxidant system changes in acute L-arginine pancreatitis in rats
166. Direct ESR measurement of free radicals in mouse pancreatic lesions
167. An essential role for free radicals and derived species in signal transduction
168. Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants
169. Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis
170. Serum ascorbic acid and gallbladder disease prevalence among US adults: The Third National Health and Nutrition Examination Survey (NHANES III)
171. The pancreas
172. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications
173. A pilot study of blood antioxidant and free radical marker profiles in patients awaiting coronary artery bypass grafting
174. Free radical scavenging enzyme activity profiles in risk assessment of idiosyncratic drug reactions: Probable mechanism for valproate-induced acute pancreatitis and hepatotoxicity
175. A radical view of gallstone aetiogenesis
176. Reactive oxygen metabolites promote cholesterol crystal formation in model bile: Role of lipid peroxidation
177. Effect of oxidative stress on receptors and signal transmission
178. Independent activation of trypsinogen and NFκB in pancreatic acinar cells during experimental acute pancreatitis
179. The effect of oxygen metabolites on the zymogens of human pancreatic proteases
180. Steatohepatitis: A tale of two 'hits'?
181. Low levels of reactive oxygen species as modulators of cell function
182. Current molecular and cellular concepts in toxicology
183. Hydrogen peroxide-induced activation of SAPK/JNK regulated by phosphatidy-linositol 3-kinase in Chinese hamster V79 cells
184. The pancreatitis-associated protein is induced by free radicals in AR4-2J cells and confers cell resistance to apoptosis
185. Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high dose antioxidant therapy
186. Chronic pancreatitis at Manchester UK: Focus on antioxidant therapy
187. Use of antioxidants to treat pain in chronic pancreatitis
188. Abnormal drug metabolism in chronic pancreatitis: Treatment with antioxidants
189. Effect of antioxidants on post-operative hyperamylasemia in coronary bypass surgery
190. Novel risk factors for atherosclerosis
191. N-acetylcysteine decreases severity of acute pancreatitis in mice
192. 2+ spiking in rat exocrine pancreas
193. Thiol metabolism and acute pancreatitis: Trying to make the pieces fit
194. Does the gabexate mesilate (FOY) protect against ERCP-related pancreatic damage?
195. Heightened free radical activity in pancreatitis
196. Paediatric and hereditary aspects of chronic pancreatitis
197. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
198. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
199. Increased susceptibility of pancreatic acinar cells to hyperstimulatory stress in F508 cystic fibrosis transmembrane conductance regulator (CFTR) heterozygous mice
200. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
201. The molecular genetics of familial intrahepatic cholestasis
202. Antioxidants in hereditary pancreatitis
203. Antioxidant status in patients with hereditary chronic pancreatitis (HCP) and alcoholics
204. Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency
205. Deficient nifedipine oxidation: A rare inherited trait associated with cystic fibrosis kindreds
206. Glutathiontransferasen und -krankheit
207. Expression of oxidative stress-responsive genes and cytokine genes during caerulein-induced acute pancreatitis
208. Effect of oxygen free radicals on the rat pancreas in vivo
209. Experimental pancreatitis induced by synthetic prooxidant tert-butyl hydroperoxide
210. Effect of hydrogen peroxide on permeability of the main pancreatic duct and morphology of the pancreas
211. Susceptibility of the exocrine pancreas to glutathione oxidation in vivo
212. Pathophysiologic role of oxygen free radicals in acute pancreatitis: Initiating event or mediator of tissue damage?
213. Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs
214. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats
215. The release of histamine by free radicals
216. Interactions of mast cell tryptase with thrombin receptors and PAR-2
217. Proteinase-activated receptors - Novel signals for gastrointestinal pathology
218. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurones through proteinase-activated receptors-1 and 2
219. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
220. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
221. Effect of human plasma-type platelet-activating factor acetyl-hydrolase in two anaphylactic shock models
222. The effect of 6-amidino-2-naphthyl-4-gluanidinobenzoate (FUT-175) on IgE antibody mediated allergic reactions in experimental animals
223. Guinea-pig mast cells and age
224. Mast cell types and cell-to-cell interactions in lymph nodes of the opossum Didelphis albiventris
225. Course of alcoholic chronic pancreatitis: A prospective clinicomorphological long-term study
226. Interstitial cystitis: A neuroimmunoendocrine disorder
227. What have mast cells to do with edema formation, the consecutive repair and fibrinolysis?
228. Mast cell recruitment in chronic pancreatitis
229. Acute pancreatitis